br Conclusions br Metastatic lung cancer is
Metastatic lung cancer is a condition with poor prognosis in regards to its high morbidity and mortality. In this study, we aimed to analyze these various management modalities specifically for patients with metastatic lung cancer affecting the spine. Our sys-tematic review on the outcomes of 1925 patients elucidated a sta-tistically and clinically significant survival advantage with non-operative treatment approaches compared with surgical manage-ment. However, we did not find there to be statistically significant differences between different subtypes of primary lung cancer nor between the number of vertebral levels involved per lesion. This analysis suggests that less aggressive approaches, such as chemotherapy, radiation, and radiofrequency ablation may be ben-eficial for patients suffering from symptomatic spinal metastases from lung cancer. More aggressive surgical treatments may be bet-ter reserved only for those with life expectancy greater than 6 months, strong candidates for surgery, and pathologic fracture or MESCC presenting with neurologic deficits. Future randomized controlled trials are warranted to control for various patient pre-sentations in order to determine the treatment algorithm that maximizes survival of metastatic lung cancer.
The authors declare that they have no competing interests. No financial support or grants are associated with this submission.
Appendix A. Supplementary data
 Bilsky MH, Laufer I, Matros E, Yamada J, Rusch VW. Advanced lung cancer: aggressive surgical therapy vertebral body involvement. Thoracic Surgery Clin 2014;24(4):423–31.
 Yoon JY, Kim TK, Kim KH. Anterolateral percutaneous vertebroplasty at C2 for lung cancer Resiniferatoxin and upper cervical facet joint block. The Clin J Pain 2008;24(7):641–6.
 Zakaria HM, Basheer A, Boyce-Fappiano D, Elibe E, Schultz L, Lee I, et al. Application of morphometric analysis to patients with lung cancer metastasis to the spine: a clinical study. Neurosurg Focus 2016;41(2):E12.  Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res: Off J Am Assoc Cancer Res 2006;12(20 Pt 2):6243s–9s.
 Sugita S, Murakami H, Kato S, Tanaka S, Tsuchiya H. Disappearance of lung adenocarcinoma after total en bloc spondylectomy using frozen tumor-bearing vertebra for reconstruction. Eur Spine J: Off Publ Eur Spine Soc, Eur Spinal Deform Soc, Eur Sect Cerv Spine Res Soc 2016;25(Suppl 1):53–7.
 Zairi F, Karnoub MA, Vieillard MH, Bouras A, Marinho P, Allaoui M, et al. Evaluation of the relevance of surgery in a retrospective case series of patients who underwent the surgical treatment of a symptomatic spine metastasis from lung cancer. Eur Spine J: Off Publ Eur Spine Soc, Eur Spinal Deform Soc, Eur Sect Cerv Spine Res Soc 2016;25(12):4052–9.
 Ha KY, Kim YH, Ahn JH, Park HY. Factors affecting survival in patients undergoing palliative spine surgery for metastatic lung and hepatocellular cancer: dose the type of surgery influence the surgical results for metastatic spine disease? Clinics in orthopedic surgery. 2015;7(3):344–50.
 Goodwin CR, Khattab MH, Sankey EW, Elder BD, Kosztowski TA, Sarabia-Estrada R, et al. Factors associated with life expectancy in patients with metastatic spine disease from adenocarcinoma of the lung. Global Spine J 2015;5(5):417–24.
 Katsenos S, Nikolopoulou M. Intramedullary thoracic spinal metastasis from small-cell lung cancer. Monaldi archives for chest disease. Archivio Monaldi per le malattie del torace 2013;79(3–4):140–2.  Tsimpas A, Post NH, Moshel Y, Frempong-Boadu AK. Large cell neuroendocrine carcinoma of the lung metastatic to the cauda equina. Spine J: Off J North Am Spine Soc 2010;10(6):e1–5.  Xu S, Yu X, Xu M. Long-term survival of a patient with lung cancer metastasis to the spine following surgical treatment combined with radiation and epithelial growth factor receptor inhibitor therapy: a case report. Exp Therapeutic Med 2015;9(1):117–9.